Schallenberger Mark A. 4

What Happened

• Mark A. Schallenberger, Chief Operating Officer of Xtant Medical Holdings, had 7,709 shares withheld on 2026-02-15 to satisfy tax withholding obligations upon vesting and settlement of restricted stock units (RSUs). The withholding was at $0.58 per share, representing ~$4,471 in value. This is a routine tax-withholding disposition rather than an open-market sale.

Key Details

• Transaction date: 2026-02-15; Filing date: 2026-02-18 (filed within the standard reporting window).
• Price per share: $0.58; Shares withheld/disposed: 7,709; Reported value: $4,471.
• Transaction code: F — shares were withheld by the issuer to pay tax withholding obligations upon vesting/settlement of RSUs (cashless tax withholding).
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Footnote highlights:
  • F1: Confirms issuer withheld shares to cover tax withholding on RSU vesting.
  • F2: Indicates the reporting person has a large aggregate of unvested awards (523,794 shares issuable under the 2023 Equity Incentive Plan and 22,250 under the 2018 plan) that vest only if employment continues through vesting dates.

Context

• This is a routine, administrative transaction to satisfy tax obligations on vested equity (not a discretionary sale or purchase). Such withholdings are common when RSUs vest and do not necessarily indicate the insider’s view on the company’s stock.
• For retail investors, purchases or open-market sales by insiders typically carry more informational weight than tax-withholding dispositions like this one.